Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back

Sandra R. Arnold, MD, MSc (she/her/hers)

Division Chief, Pediatric Infectious Diseases
University of Tennessee Health Science Center
Memphis, Tennessee, United States

Presentation(s):

  • That antibiotics should be routinely discontinued after 2 days in children with culture-negative severe sepsis - Pro

    Friday, May 3, 2024
    3:45 PM – 3:58 PM ET

    Disclosure(s): Enanta (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

  • The New Guideline for Joint Infections in Children - Review and Discussion

    Monday, May 6, 2024
    8:00 AM – 9:30 AM ET

    Disclosure(s): Enanta (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

  • New ABA Guideline: Introduction, Diagnostic Considerations

    Monday, May 6, 2024
    8:00 AM – 8:20 AM ET

    Disclosure(s): Enanta (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

  • Summary Q&A (full panel)

    Monday, May 6, 2024
    9:15 AM – 9:30 AM ET

    Disclosure(s): Enanta (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

Email Sandra